跳至主要内容
临床试验/NCT00081965
NCT00081965已完成不适用

Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients: A Randomized Controlled Trial

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2004年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Frequency and severity of hot flashes, as measured by a hot flash diary

研究概览

简要总结

RATIONALE: Acupuncture may help relieve hot flashes in women with breast cancer. It is not yet known whether acupuncture is more effective than a placebo in treating hot flashes in women with breast cancer

PURPOSE: This randomized clinical trial is studying acupuncture to see how well it works compared to a placebo in treating hot flashes in women with breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine whether acupuncture, compared to placebo, reduces the incidence of hot flashes in women with breast cancer.

Secondary

  • Determine the long-term effects of acupuncture on hot flashes.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Supportive Care

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Diagnosis of breast cancer (including in situ disease)
  • •Must be receiving treatment for breast cancer at Memorial Sloan Kettering Cancer Center (MSKCC) or its regional site (Commack)
  • •Has an average of 3 or more hot flashes a day during 1 week of baseline diary recording
  • •Hormone receptor status not specified
  • •PATIENT CHARACTERISTICS:
  • •Pre- or postmenopausal
  • •Karnofsky performance status 70-100%
  • •Ambulatory
  • •No skin infection
  • •PRIOR CONCURRENT THERAPY:
  • •More than 3 weeks since prior and no concurrent treatment with any of the following during the 6 week evaluation period of the trial:
  • •Initiation of a new chemotherapy regimen
  • •Initiation of immunotherapy
  • •Initiation of radiotherapy
  • •Initiation or cessation of hormonal therapy
  • •More than 6 weeks since prior acupuncture treatment (6 months for acupuncture specifically for the treatment of hot flashes)
  • •No concurrent pharmacological treatment for hot flashes unless dose has been stable for 4 weeks
  • •No concurrent selective serotonin reuptake inhibitors (SSRIs) unless dose has been stable for 4 weeks

排除标准

  • 未提供

结局指标

主要结局

Frequency and severity of hot flashes, as measured by a hot flash diary

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验